Table 3.
Correlation between changes in bile acids and changes in Pro-C3 in the pooled NASH and PSC populations.
| Percent change in bile acids from baseline to week 12 | Percent change in Pro-C3 from baseline to week 12 |
|
|---|---|---|
| rho | p value | |
| Primary bile acids | ||
| Glycine-conjugated primary bile acids | ||
| GCA (μmol/L) | 0.33 | <0.001 |
| GCDCA (μmol/L) | 0.25 | <0.001 |
| Taurine-conjugated primary bile acids | ||
| TCA (μmol/L) | 0.16 | 0.02 |
| TCDCA (μmol/L) | 0.06 | 0.38 |
| Unconjugated primary bile acids | ||
| CA (μmol/L) | 0.23 | 0.001 |
| CDCA (μmol/L) | 0.17 | 0.01 |
| Secondary bile acids | ||
| Glycine-conjugated secondary bile acids | ||
| GDCA (μmol/L) | 0.34 | <0.001 |
| GLCA (μmol/L) | 0.30 | <0.001 |
| Taurine-conjugated secondary bile acids | ||
| TDCA (μmol/L) | 0.31 | <0.001 |
| TLCA (μmol/L) | -0.01 | 0.86 |
| Unconjugated secondary bile acids | ||
| DCA (μmol/L) | 0.36 | <0.001 |
| LCA (μmol/L) | 0.30 | <0.001 |
Data are presented as correlation coefficients. Values of p by Spearman’s method.
CA, cholic acid; CDCA, chenodeoxycholic acid; DCA, deoxycholic acid; GCA, glycocholic acid; GCDCA, glycochenodeoxycholic acid; GDCA, glycodeoxycholic acid; GLCA, glycolithocholic acid; LCA, lithocholic acid; TCA, taurocholic acid; TCDCA, taurochenodeoxycholic acid; TDCA, taurodeoxycholic acid; TLCA, taurolithocholic acid.